医学
沃马克
针灸科
骨关节炎
随机对照试验
置信区间
物理疗法
麻醉
内科学
替代医学
病理
作者
Jiali Liu,Ying Li,Ling Li,Xiaochao Luo,Ning Li,Xuguang Yang,Hongxing Zhang,Zhibin Liu,Deying Kang,Yanan Luo,Yanmei Liu,Yulong Jia,Yan Ren,Minghong Yao,Yuning Wang,Jin Chen,Me-Wu-Jia Maiji,Kang Zou,Ling Zhao,Fanrong Liang,Xin Sun
标识
DOI:10.1186/s13020-022-00626-3
摘要
The acupoint selections impact the effects of acupuncture, and preliminary evidence showed potential connection between pain threshold (PT) and acupuncture response. This study examined whether acupuncture at acupoints with lower PT versus higher PT would yield different effects in patients with knee osteoarthritis (KOA).In this multicenter randomized clinical trial, patients were randomly assigned (1:1:1) to receive acupuncture at acupoints with lower PT (LPT group), acupuncture at acupoints with higher PT (HPT group), and no acupuncture (waiting-list group). PT was measured with electronic von Frey detector. The primary outcome was the change in WOMAC total score from baseline to 16 weeks, and the secondary outcomes were SF-12 score, and active knee range of motion (ROM). Intention-to-treat analysis was conducted with linear mixed-effect model.Among 666 randomized patients, 625 (93.84%) completed the study. From baseline to 16 weeks, patients in the LPT group versus HPT group had similar effects in reducing WOMAC total score (adjusted mean difference (MD) 2.21, 95% confidence interval (CI) -2.51 to 6.92, P = 0.36), while a greater reduction in WOMAC total score was observed in LPT group (-9.77, 95% CI -14.47 to -5.07, P < 0.001) and HPT group (-11.97, 95% CI -16.71 to -7.24, P < 0.001) compared with waiting-list group. There were no differences in SF-12 score and knee ROM between LPT versus HPT groups.Our findings found that the effects of acupuncture at acupoints with lower versus higher PT were similar, both were effective for patients with KOA.ClinicalTrials.gov identifier: NCT03299439. Registered 3 October 2017, https://clinicaltrials.gov/ct2/show/NCT03299439.
科研通智能强力驱动
Strongly Powered by AbleSci AI